Survey of HLA Distribution in Patients with End Stage Renal Disease Secondary to Reflux Nephropathy
PDF
Cite
Share
Request
Original Investigation
P: 255-257
September 2018

Survey of HLA Distribution in Patients with End Stage Renal Disease Secondary to Reflux Nephropathy

İstanbul Med J 2018;19(3):255-257
1. Department of Pediatric Surgery, Division of Pediatric Urology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey
2. Department of General Surgery, İstanbul University- Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey
3. Department of Internal Medicine, Division of Nephrology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey
4. Blood Bank Tissue Typing Laboratory, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey
5. Department of Internal Medicine, Division of Pediatric Nephrology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey
No information available.
No information available
Received Date: 07.10.2017
Accepted Date: 20.01.2018
PDF
Cite
Share
Request

ABSTRACT

Introduction:

To evaluate the human leukocyte antigen (HLA) types of patients with vesicoureteral reflux (VUR) who underwent renal transplantation for end-stage renal disease (ESRD) to investigate for any significant association.

Methods:

This retrospective study comprised 26 patients (male, 15; female, 11) with ESRD secondary to VUR (ESRD/VUR group) who underwent renal transplantation, and 38 healthy donors (female, 24; male, 14) were randomized in the control group. The Single Specific Primer-Polymerase Chain Reaction (low resolution) method was performed for HLA typing. The statistical analyses included chi-square test and calculation of odds ratio (OR).

Results:

The median age was 25.2 years (R, 10-41) in the ESRD/VUR group and 43.9 (R, 20-76) in the control group. A statistically significant difference between HLA A and B types was not observed. The HLA DRB1*01 was significantly higher in the ESRD/VUR group than in the control group (p=0,024). The OR for the HLA DRB1*01 was 2.727. The risk of developing ESRD secondary to VUR was 2.727 times higher in the presence of the HLA DRB1*01.

Conclusion:

An association between HLA DRB1*01 and ESRD secondary to VUR was established. The HLA DRB1*01 antigen could be interpreted as a poor prognostic factor of reflux nephropathy. This finding should be supported by further studies.

2024 ©️ Galenos Publishing House